SonoThera selected to Endpoints 11 list of most promising biotech companies in 2026. Learn more.

End­points 11: SonoThera is mak­ing waves in a bold new ap­proach to non-vi­ral gene ther­a­py

September 25, 2026

Inquiries about our Clinical Research

Contact Us